RaySearch Laboratories AB/Skr RAY B
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About RaySearch Laboratories AB
RaySearch Laboratories AB is a medical technology company based in Sweden that specializes in software solutions for radiation therapy used in cancer treatment. The company's primary product is RayStation, an advanced treatment planning system that integrates a comprehensive set of tools for creating radiation therapy plans. Founded in 2000, RaySearch focuses heavily on research and development to innovate in adaptive therapy, automated planning, and machine learning. Its strategic partnerships with major equipment vendors expand its geographic presence, serving clinics and hospitals worldwide. The company's competitive strength lies in its advanced algorithms and focus on improving patient outcomes and treatment workflows.
Ticker
Skr RAY B
Sector
Primary listing
XSTO
Employees
465
Headquarters
Stockholm, Sweden
Website
RAY B Metrics
BasicAdvanced
kr 7.4bn
33.12
kr 6.53
0.93
kr 4.00
1.85%
Price and volume
Market cap
kr 7.4bn
Beta
0.93
52-week high
kr 373.50
52-week low
kr 166.80
Average daily volume
159k
Dividend rate
kr 4.00
Financial strength
Current ratio
1.792
Quick ratio
1.705
Long term debt to equity
28.656
Total debt to equity
36.185
Dividend payout ratio (TTM)
45.85%
Interest coverage (TTM)
80.60%
Profitability
EBITDA (TTM)
351.5
Gross margin (TTM)
92.41%
Net profit margin (TTM)
17.20%
Operating margin (TTM)
24.74%
Effective tax rate (TTM)
21.25%
Revenue per employee (TTM)
kr 2,800,000
Management effectiveness
Return on assets (TTM)
9.86%
Return on equity (TTM)
22.82%
Valuation
Price to earnings (TTM)
33.115
Price to revenue (TTM)
5.692
Price to book
7.07
Price to tangible book (TTM)
15.81
Price to free cash flow (TTM)
60.071
Free cash flow yield (TTM)
1.66%
Free cash flow per share (TTM)
3.602
Dividend yield (TTM)
1.85%
Forward dividend yield
1.85%
Growth
Revenue change (TTM)
2.95%
Earnings per share change (TTM)
0.19%
3-year revenue growth (CAGR)
14.62%
10-year revenue growth (CAGR)
12.39%
3-year earnings per share growth (CAGR)
116.94%
10-year earnings per share growth (CAGR)
13.54%
10-year dividend per share growth (CAGR)
31.95%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs